| Title |
The Future of Clinical Trial Design in Oncology
|
|---|---|
| Published in |
Cancer Discovery, April 2021
|
| DOI | 10.1158/2159-8290.cd-20-1301 |
| Pubmed ID | |
| Authors |
Anna Spreafico, Aaron R Hansen, Albiruni R Abdul Razak, Philippe L Bedard, Lillian L Siu |
X Demographics
The data shown below were collected from the profiles of 75 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 24 | 32% |
| Canada | 4 | 5% |
| Brazil | 4 | 5% |
| Spain | 3 | 4% |
| Mexico | 2 | 3% |
| United Kingdom | 2 | 3% |
| Italy | 2 | 3% |
| Belgium | 2 | 3% |
| Colombia | 2 | 3% |
| Other | 8 | 11% |
| Unknown | 22 | 29% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 37 | 49% |
| Scientists | 24 | 32% |
| Practitioners (doctors, other healthcare professionals) | 9 | 12% |
| Science communicators (journalists, bloggers, editors) | 5 | 7% |
Mendeley readers
The data shown below were compiled from readership statistics for 160 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 160 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 24 | 15% |
| Other | 13 | 8% |
| Student > Ph. D. Student | 11 | 7% |
| Student > Master | 10 | 6% |
| Student > Bachelor | 6 | 4% |
| Other | 28 | 18% |
| Unknown | 68 | 43% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 27 | 17% |
| Biochemistry, Genetics and Molecular Biology | 14 | 9% |
| Pharmacology, Toxicology and Pharmaceutical Science | 10 | 6% |
| Agricultural and Biological Sciences | 7 | 4% |
| Nursing and Health Professions | 5 | 3% |
| Other | 25 | 16% |
| Unknown | 72 | 45% |
Attention Score in Context
This research output has an Altmetric Attention Score of 40. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 April 2023.
All research outputs
#1,046,692
of 25,721,020 outputs
Outputs from Cancer Discovery
#545
of 4,152 outputs
Outputs of similar age
#29,118
of 456,204 outputs
Outputs of similar age from Cancer Discovery
#44
of 167 outputs
Altmetric has tracked 25,721,020 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 4,152 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 22.2. This one has done well, scoring higher than 86% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 456,204 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 93% of its contemporaries.
We're also able to compare this research output to 167 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 73% of its contemporaries.